Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.15.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.15.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AY.36 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AY.43.4 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.57 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
AY.3.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-15913.9Singapore
JN.1.28.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EG.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.39.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XDQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GY.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.107SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13940.9Singapore
LC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.172SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.110SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.320SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.91SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.55.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LQ.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FY.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDKSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.54SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.120 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used